IQVIA says it has made ‘massively important’ time savings possible in Covid-19 clinical trials
It would be "very, very difficult" to conduct a UK-wide Covid-19 clinical trial quickly enough without IQVIA's overarching…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
26 May 20
It would be "very, very difficult" to conduct a UK-wide Covid-19 clinical trial quickly enough without IQVIA's overarching…
26 May 20
The acquisition will allow Roche to access Stratos Genomics’ advanced Sequencing by Expansion (SBX) chemistry, and complement the…
26 May 20
Results from the Phase 3 ALTA 1L Trial demonstrated ALUNBRIG as a better treatment for ALK+ Metastatic NSCLC,…
25 May 20
Despite the rapid growth in demand for drugs, the pharma industry has not kept pace - meaning it…
Pharmaceuticals and MedicinesContract ManufacturingPharmaceuticals
Analysts at GlobalData believe the decrease in FDA drug approvals is due to a US government shutdown in…
22 May 20
Samsung Biologics is expected to provide GSK with additional capacity for large-scale manufacture of biopharmaceutical products
22 May 20
Remdesivir has been recently granted the US Food and Drug Administration (FDA) Emergency Use Authorisation (EUA) for the…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
21 May 20
The FDA approval was supported by results from the Phase 3 PROfound study that evaluated the efficacy and…
21 May 20
CanSinoBIO will hold rights to commercialise the vaccine product in Asia, except in Japan, while PNI will retain…
20 May 20
Zolgensma showed therapeutic benefit in pre-symptomatic and symptomatic SMA, including prolonged event-free survival and achievement of motor milestones